| Literature DB >> 30995092 |
Alberto Diaz de Leon1, Matthew S Davenport2, Stuart G Silverman3, Nicola Schieda4, Jeffrey A Cadeddu1,5, Ivan Pedrosa1,5,6.
Abstract
OBJECTIVE. Renal masses comprise a heterogeneous group of pathological conditions, including benign and indolent diseases and aggressive malignancies, complicating management. In this article, we explore the emerging role of imaging to provide a comprehensive noninvasive characterization of a renal mass-so-called "virtual biopsy"-and its potential use in the management of patients with renal tumors. CONCLUSION. Percutaneous renal mass biopsy (RMB) remains a valuable method to provide a presurgical histopathologic diagnosis of renal masses, but it is an invasive procedure and is not always feasible. Accumulating data support the use of imaging features to predict histopathology of renal masses. Imaging may help address some of the inherent limitations of RMB, and in certain settings, a multimodal clinical approach may allow decreasing the need for RMB.Entities:
Keywords: CT; MRI; renal cell carcinoma; renal mass; renal mass biopsy
Year: 2019 PMID: 30995092 PMCID: PMC6800762 DOI: 10.2214/AJR.19.21172
Source DB: PubMed Journal: AJR Am J Roentgenol ISSN: 0361-803X Impact factor: 3.959